Harout Semerjian

Harout Semerjian

President and Chief Executive Officer (as of August 7, 2025)atGeron· In the 2025 proxy

Pay in FY2025Geron stock -62.7% the same year

Harout Semerjian was paid $10.2M in FY2025 (Dec). Geron stock fell 62.7% that year.

Pay$100 in the stock at the end of FY24 → $37
Pay is from the Summary Compensation Table of each Geron proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeronPublic company · 1 yr
    • President and Chief Executive Officer (as of August 7, 2025)2025 – Present · 1 yrStock in role -71%
  2. RenovoRxPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Ayala PharmaceuticalsPublic company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  4. Biotechnology Innovation OrganizationPublic company
    • Director? – PresentNo stock prices for these years
  5. AthenexPublic company · 3 yr
    • Director2020 – 2023 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?